Home Cardiac Insight, Inc.

Cardiac Insight, Inc.

Cardiac Insight, Inc. Partners with VivoSense® (Vivonoetics, Inc.)

“Sophisticated new analytics are the key to making sense of the complex data sets generated by human study participants in response to new drug candidates and genetics-driven population health research. Using the class-leading Cardiac Insight Cardea SOLO™ ECG Sensor data with VivoSense software, data cleaning, robust analytics and regulatory-compliant biomarkers, we expect to enable new discoveries,” said Dudley Tabakin, Chief Executive Officer and Co-Founder of VivoSense.

Cardiac Insight’s Wearable ECG Sensor, Cardea SOLO™, Continues to Attract Premier Cardiology Groups Across the U.S.; Announces Baltimore Heart Associates and Regional Cardiac Arrhythmia as Customers

9/6/18: The company reports both cardiology groups selected Cardea SOLO for its unique ability to provide a higher standard of ambulatory cardiac care, improved operational and financial metrics for their practices, and positive patient experiences.